LONCAR CHINA BIOPHARMA ETF (CHNA) Stock News

USA - NASDAQ:CHNA - US26922A3703 - ETF

13.53 USD

-0.01 (-0.07%)

Last: 10/20/2023, 8:00:00 PM

Technical Analysis

CHNA Latest News, Press Relases and Analysis

All

Press Releases

4 years ago - By: Investor's Business Daily - Mentions: BGNE ZLAB HCM YUMC ...

Why BeiGene — And 2 Other China-Based Biotechs — Are In Trouble

5 years ago - By: Investor's Business Daily - Mentions: LLY MRK BMY

Eli Lilly Pact With China Partner On Lymphoma Drug Raises Pricing Question

5 years ago - By: Barron's - Mentions: LK MCHI FXI BABA ...

China Stocks Are Still Worth Buying. ETFs Offer A Targeted Way

6 years ago - By: Seeking Alpha - Mentions: BIB THW ARKG BME ...

End-of-year drug approvals in U.S. associated with more adverse events - study

6 years ago - By: Seeking Alpha - Mentions: BIB THW ARKG BME ...

Senate backs Hahn to lead FDA

6 years ago - By: InvestorPlace - Mentions: AMGN BGNE

The Most Overlooked Investment Theme Heading Into 2020

6 years ago - By: InvestorPlace - Mentions: ILMN GH

VIDEO: Biotech Stocks and the Future of Healthcare

6 years ago - By: Loncar Investments, LLC

Loncar China BioPharma ETF (CHNA) Celebrates One-Year Anniversary

7 years ago - By: TalkMarkets - Mentions: BX AVEO

Week In Review: Shanghai ChemPartner, A China CRO/CMO, Completes Reverse Merger

7 years ago - By: Benzinga - Mentions: CBPO CNCR BGNE

Hone In On Health Care In China With This New ETF

7 years ago - By: MarketWatch - Mentions: COMP KURE BGNE

New ETF allows you to invest in up-and-coming Chinese biotech companies

7 years ago - By: Loncar Investments, LLC - Mentions: CNCR

Loncar China BioPharma ETF (CHNA) Launches on Nasdaq